In our work, resiquimod encapsulated in mUNO-coated lignin nanoparticles slowed down the tumor growth and significantly transformed the immune landscape in the tumor; decreased M2-like TAMs, and increased CD8 T-cells, M1-like TAMs, activated dendritic cells and IFN-γ. The gene discussed is CD8A; the disease is neoplasm.